{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T17:46:40Z","timestamp":1759600000346},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"S2","license":[{"start":{"date-parts":[[1991,10,1]],"date-time":"1991-10-01T00:00:00Z","timestamp":686275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1991,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Patients with mild asymptomatic primary hyperparathyroidism who do not meet currently accepted guidelines for surgery may be followed medically. General medical management of these individuals should be directed toward maintaining adequate hydration, therapy of hypertension, and avoiding immobilization. Diuretics should be used only with caution. Moderate dietary calcium intake (500\u2013800 mg\/day) should be encouraged. Propranolol and cimetidine are not useful in the therapy of primary hyperparathyroidism. Oral phosphate is efficacious in lowering serum and urinary calcium. However, because of concerns related to ectopic calcification, phosphate is usually reserved for those patients who meet surgical guidelines but who are not to undergo surgery. Bisphosphonates, potent inhibitors of osteoclast-mediated bone resorption, have been shown to lower serum and urinary calcium in patients with primary hyperparathyroidism. However, long-term data on their efficacy in this disorder are not yet available. The use of bisphosphonates at the present time is generally restricted to the research setting. More potent bisphosphonates as well as the design of newer agents that interfere with parathyroid hormone secretion may become very useful in future approaches to the medical management of primary hyperparathyroidism.<\/jats:p>","DOI":"10.1002\/jbmr.5650061427","type":"journal-article","created":{"date-parts":[[2010,2,3]],"date-time":"2010-02-03T17:50:29Z","timestamp":1265219429000},"page":"S131-S134","source":"Crossref","is-referenced-by-count":8,"title":["Journal of Bone and Mineral Research"],"prefix":"10.1093","volume":"6","author":[{"given":"Elizabeth","family":"Shane","sequence":"first","affiliation":[{"name":"Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1991,10,1]]},"reference":[{"key":"2024012712424595900_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.pa.26.040186.000533","article-title":"Renal calcium metabolism and diuretics","volume":"26","author":"Stier","year":"1986","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2024012712424595900_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0272-6386(85)80128-1","article-title":"Diuretics and calcium metabolism","volume":"5","author":"Sutton","year":"1985","journal-title":"Am J Kidney Dis"},{"key":"2024012712424595900_bib3","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJM198205133061903","article-title":"Calcium homeostasis in immobilization: An example of resorptive hypercalciuria","volume":"306","author":"Stewart","year":"1982","journal-title":"N Engl J Med"},{"key":"2024012712424595900_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1210\/jcem-46-2-267","article-title":"Dispersed cells prepared from human parathyroid glands: Distinct calcium sensitivity of adenomas vs primary hyperplasia","volume":"46","author":"Brown","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012712424595900_bib5","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJM198510313131805","article-title":"Sensitivity of the parathyroid hormone\u20141,25-dihydroxyvitamin D axis to variations in calcium intake in patients with primary hyperparathyroidism","volume":"313","author":"Insogna","year":"1985","journal-title":"N Engl J Med"},{"key":"2024012712424595900_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1210\/edrv-1-4-319","article-title":"Biogenic amines and the secretion of parathyroid hormone and calcitonin","volume":"1","author":"Heath","year":"1980","journal-title":"Endocr Rev"},{"key":"2024012712424595900_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0022-4804(81)90074-3","article-title":"The influence of beta-adrenergic catecholamines upon cyclic AMP and parathyroid hormone secretion in human parathyroid glands","volume":"30","author":"Derenoncourt","year":"1981","journal-title":"J Surg Res"},{"key":"2024012712424595900_bib8","doi-asserted-by":"crossref","first-page":"740","DOI":"10.7326\/0003-4819-91-5-740","article-title":"Effect of long-term propranolol administration on parathyroid hormone and calcium concentration in primary hyperparathyroidism","volume":"91","author":"Caro","year":"1979","journal-title":"Ann Intern Med"},{"key":"2024012712424595900_bib9","first-page":"426","volume-title":"Endocrinology of Calcium Metabolism","author":"Rao","year":"1978"},{"key":"2024012712424595900_bib10","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0140-6736(79)91308-4","article-title":"Propranolol in primary hyperparathyroidism (letter)","volume":"1","author":"Monson","year":"1979","journal-title":"Lancet"},{"key":"2024012712424595900_bib11","first-page":"98","article-title":"Parathyroid hormone secretion in primary hyperparathyroidism: Retained control by calcium with impaired control by beta-adrenergic system","volume":"3","author":"Kukreja","year":"1980","journal-title":"Miner Electrolyte Metab"},{"key":"2024012712424595900_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.0954-6820.1982.tb01897.x","article-title":"Effects of beta-adrenergic blockade on serum parathyroid hormone in normal subjects and patients with primary hyperparathyroidism","volume":"211","author":"Ljunghall","year":"1982","journal-title":"Acta Med Scand"},{"key":"2024012712424595900_bib13","first-page":"1148","article-title":"Medical treatment of primary hyperparathyroidism: Effects on parathormone and vitamin D metabolites","volume":"23","author":"Foldes","year":"1987","journal-title":"Isr J Med Sci"},{"key":"2024012712424595900_bib14","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1210\/jcem-51-6-1325","article-title":"Histamine receptors on dispersed parathyroid cells in pathological human parathyroid tissue","volume":"51","author":"Brown","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012712424595900_bib15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1210\/jcem-52-1-122","article-title":"Parathyroid hormone secretion in normal man and in primary hyperparathyroidism: Role of histamine H2 receptors","volume":"52","author":"Williams","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012712424595900_bib16","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0140-6736(80)91117-4","article-title":"Effect of cimetidine on circulating parathyroid hormone in primary hyperparathyroidism","volume":"1","author":"Sherwood","year":"1980","journal-title":"Lancet"},{"key":"2024012712424595900_bib17","first-page":"1134","article-title":"Cimetidine and hyperparathyroidism (letter)","volume":"1","author":"Palmer","year":"1980","journal-title":"Lancet"},{"key":"2024012712424595900_bib18","first-page":"980","article-title":"Cimetidine in hyperparathyroidism (letter)","volume":"1","author":"Heath","journal-title":"Lancet"},{"key":"2024012712424595900_bib19","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(80)91576-7","article-title":"Cimetidine and hyperparathyroidism (letter)","volume":"e1","author":"Awoke","year":"1980","journal-title":"Lancet"},{"key":"2024012712424595900_bib20","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0140-6736(80)91916-9","article-title":"Cimetidine in primary hyperparathyroidism (letter)","volume":"2","author":"Ljunghall","year":"1980","journal-title":"Lancet"},{"key":"2024012712424595900_bib21","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1210\/jcem-51-4-912","article-title":"Failure of cimetidine to affect calcium homeostasis in familial primary hyperparathyroidism (multiple endocrine neoplasia, type 1)","volume":"51","author":"Robinson","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012712424595900_bib22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1172\/JCI100423","article-title":"Studies in parathyroid physiology","volume":"11","author":"Albright","year":"1932","journal-title":"J Clin Invest"},{"key":"2024012712424595900_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM196601062740101","article-title":"Inorganic phosphate treatment of hypercalcemia of diverse etiologies","volume":"274","author":"Goldsmith","year":"1966","journal-title":"N Engl J Med"},{"key":"2024012712424595900_bib24","first-page":"1886","article-title":"Studies of the mechanism by which phosphate infusion lowers serum calcium","volume":"45","author":"Herbert","year":"1966","journal-title":"concentration"},{"key":"2024012712424595900_bib25","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/jcem-56-5-953","article-title":"A detailed evaluation of oral phosphorus therapy in selected patients with primary hyperparathyroidism","volume":"56","author":"Broadus","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012712424595900_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF02441167","article-title":"Diphosphonates","volume":"27","author":"Fleisch","year":"1979","journal-title":"Calcif Tissue Int"},{"key":"2024012712424595900_bib27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/j.1552-4604.1977.tb04624.x","article-title":"Metabolic effects of diphosphonate in primary hyperparathyroidism","volume":"17","author":"Kaplan","year":"1977","journal-title":"J Clin Pharmacol"},{"key":"2024012712424595900_bib28","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1001\/jama.1983.03330390067035","article-title":"Treatment of hyperparathyroidism with etidronate disodium","volume":"249","author":"Licata","year":"1983","journal-title":"JAMA"},{"key":"2024012712424595900_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7326\/0003-4819-95-1-23","article-title":"Effects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism","volume":"95","author":"Shane","year":"1981","journal-title":"Ann Intern Med"},{"key":"2024012712424595900_bib30","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/bmj.286.6365.587","article-title":"Drug treatment of primary hyperparathyroidism: Use of clodronate disodium","volume":"286","author":"Douglas","year":"1983","journal-title":"Br Med J"},{"issue":"Suppl. 1","key":"2024012712424595900_bib31","first-page":"569","article-title":"Clodronate in the medical management of hyperparathyroidism","volume":"8","author":"Hamdy","year":"1987","journal-title":"Bone"},{"key":"2024012712424595900_bib32","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2265.1990.tb00504.x","article-title":"Regulation of calcium parathyroid hormone feedback in primary hyperparathyroidism: Effects of bisphosphonate treatment","volume":"33","author":"Adami","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024012712424595900_bib33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1445-5994.1987.tb05052.x","article-title":"Aminohydroxypropylidene diphosphonate treatment of hypercalcemic crisis due to primary hyperparathyroidism","volume":"17","author":"Evans","year":"1987","journal-title":"Aust N Z J Med"},{"key":"2024012712424595900_bib34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2265.1990.tb00869.x","article-title":"Aminopropylidine diphosphonate (APD) in mild primary hyperparathyroidism: Effect on clinical status","volume":"32","author":"Schmidli","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024012712424595900_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/978-1-4684-5206-8_45","article-title":"Mechanism of the hypocalcemic agent WR-2721 and its acute and chronic application in eu- and hyperparathyroidism","volume":"208","author":"Hirschel-Scholz","year":"1986","journal-title":"Adv Exp Med Biol"},{"key":"2024012712424595900_bib36","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1016\/0006-2952(86)90701-X","article-title":"Dual effects of a new hypocalcemic agent, WR-2721, on cytoplasmic Ca2+ and parathyroid hormone release of dispersed parathyroid cells from patients with hyperparathyroidism","volume":"35","author":"Larsson","year":"1986","journal-title":"Biochem Pharmacol"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.5650061427","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/6\/S2\/S131\/56432590\/5650061427.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/6\/S2\/S131\/56432590\/5650061427.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:53:33Z","timestamp":1710341613000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/6\/S2\/S131-S134\/7502171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,10,1]]},"references-count":36,"journal-issue":{"issue":"S2","published-online":{"date-parts":[[1991,10,1]]},"published-print":{"date-parts":[[1991,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.5650061427","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1991,10,1]]},"published":{"date-parts":[[1991,10,1]]}}}